S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
The only accurate crypto trading system I know … (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
The only accurate crypto trading system I know … (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
The only accurate crypto trading system I know … (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
The only accurate crypto trading system I know … (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
Free Trial
OTCMKTS:GTSIF

Lobe Sciences (GTSIF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free GTSIF Stock Alerts
$0.02
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.0153
▼
$0.0153
50-Day Range
$0.0014
▼
$0.0190
52-Week Range
$0.03
▼
$0.22
Volume
66 shs
Average Volume
595,549 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChart
GTSIF stock logo

About Lobe Sciences Stock (OTCMKTS:GTSIF)

Lobe Sciences Ltd., a technology and services company, provides real estate, financial, management, intellectual property, and branding support for development of transformational medicine in the United States. The company intends to develop psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. It also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

GTSIF Stock Price History

GTSIF Stock News Headlines

May 5, 2023 | finance.yahoo.com
Lobe Sciences, Ltd. Provides Update on Vitamind
April 21, 2023 | benzinga.com
Lobe Sciences Stock (OTC:LOBEF), Dividends
April 19, 2024 | Paradigm Press (Ad)
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
March 11, 2023 | finance.yahoo.com
Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
February 23, 2023 | proactiveinvestors.com
Lobe Sciences to advance two new chemical entities through exclusive agreement with Quality Chemical Laboratories
January 26, 2023 | benzinga.com
Lobe Sciences Board of Directors Elects to Receive Shares in Lieu of Cash for All Board Fees
November 8, 2022 | finance.yahoo.com
Lobe Sciences Ltd. (LOBE.CN)
June 16, 2022 | finance.yahoo.com
Lobe Sciences Announces Roadmap for Remainder of 2022 and Early 2023
April 19, 2024 | Paradigm Press (Ad)
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
March 30, 2022 | proactiveinvestors.com
Lobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 with psilocybin and NAC
December 10, 2021 | finance.yahoo.com
Lobe Sciences Ltd. (LOBEF)
November 15, 2021 | finance.yahoo.com
Lobe Sciences Announces Common Stock to Trade Under the Symbol "LOBEF" in US Markets
November 8, 2021 | finance.yahoo.com
Lobe Sciences Invites You to Join Us at the Q4 Virtual Investor Summit
October 6, 2021 | finance.yahoo.com
Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of Advisors
October 5, 2021 | finance.yahoo.com
Lobe Sciences to Present at the BioFuture 2021 & MoneyShow Virtual Expo Investor Conferences
October 4, 2021 | finance.yahoo.com
Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD
September 28, 2021 | finance.yahoo.com
Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates are Significantly More Effective Than Monotherapy in mTBI and PTSD
September 27, 2021 | finance.yahoo.com
Lobe Sciences to Present at the Benzinga Healthcare Small Cap Conference
September 16, 2021 | finanznachrichten.de
Lobe Sciences Ltd.: Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
September 15, 2021 | finance.yahoo.com
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
September 13, 2021 | finance.yahoo.com
Lobe Sciences Provides Corporate Update to Investors and Stakeholders
September 10, 2021 | finance.yahoo.com
Lobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment Conference
August 25, 2021 | yahoo.com
Beyoncé Channeled Audrey Hepburn in a Chic LBD and 128.54 Carat "Tiffany Diamond" Necklace
August 23, 2021 | finance.yahoo.com
Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board
See More Headlines
Receive GTSIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lobe Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:GTSIF
CUSIP
N/A
CIK
N/A
Web
www.greenstarbiosciences.com
Phone
604-834-9499
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jonathan R. Gilbert (Age 50)
    Exec. Chairman
  • Mr. Philip J. Young (Age 64)
    CEO, Corp. Sec. & Director
  • Mr. Brian Zasitko
    Chief Financial Officer
  • Mr. Daniel S. McAtee (Age 55)
    Chief Operating Officer
  • Mr. Maghsoud Dariani (Age 68)
    Chief Science Officer

Key Competitors

View All Competitors

GTSIF Stock Analysis - Frequently Asked Questions

How have GTSIF shares performed in 2024?

Lobe Sciences' stock was trading at $0.0120 on January 1st, 2024. Since then, GTSIF stock has increased by 27.5% and is now trading at $0.0153.
View the best growth stocks for 2024 here.

How do I buy shares of Lobe Sciences?

Shares of GTSIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GTSIF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace